Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation
University of California, San Diego
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
University of Geneva, Switzerland
PRoMiSS: Psilocybin and the Role of Music in Set and Setting
Johns Hopkins University
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Cybin IRL Limited
Ketamine Effects on Learning In Eating Disorders
Amanda Downey, MD
Psilocybin With Intracranial Neural Sensing
Joshua Woolley, MD, PhD
Induction of Dreaming With EEG and Anesthesia in Healthy Adults
Stanford University
High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
ARQ National Psychotrauma Centre
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
University of Texas at Austin
Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
Psyrin Inc.
Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
University of Pittsburgh
Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
Yale University
MDMA Plus Exposure Therapy for PTSD
Emory University
Long Term Follow Up KET-PD
Yale University
Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan
Brigham and Women's Hospital
Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
Kernel
Comparative Analysis of Spinal Anesthesia Versus General Anesthesia for vNOTES
University of Kansas Medical Center
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
Felix Mueller
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Medical University of Gdansk
Observational Study of Ketamine Infusions for the Treatment of Chronic Pain
Theresa Lii
Long-term Pain Modulation by Intravenous Esketamine in CRPS
Erasmus Medical Center
Effect of Ketamine and Etomidate During RSI on Long Term Outcomes
Vanderbilt University Medical Center
GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries
Hospital for Special Surgery, New York
Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries
Mayo Clinic
Group PACBT for Depression
University of California, Los Angeles
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.
Gabriella Gobbi
Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations
Oman Medical Speciality Board
Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery.
Ente Ospedaliero Ospedali Galliera
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
University of Calgary
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Indiana University
Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)
NYU Langone Health
Shortened LSD Intervention for Major Depressive Disorder
Johns Hopkins University
Transition From Acute to Chronic Opioid Use and Chronic Pain
Jacques E. Chelly
Anesthesia-Masked Psilocybin Therapy for Major Depression
Stanford University
Ketamine HCl Prolonged Release Oral Tablets for CRPS
University of Southern California
Psilocybin After Trauma Surgery for Pain
Trent Emerick
Psilocybin Administration With 5-HT1a Blockade
Johns Hopkins University
Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers
National Center for Complementary and Integrative Health (NCCIH)
A Study of Psychedelics in Healthy Older Adults With Low Well-being
Jennifer Mitchell
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
VA Office of Research and Development
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
University of Wisconsin, Madison
Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy Controls
University Hospital, Basel, Switzerland
Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain
Yale University
Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression
University of Washington
Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression
University of Rochester
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
M.D. Anderson Cancer Center
Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy
Fundacio Puigvert
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.